By Professor Michelle Haber

Journal articles

Dorstyn L; Puccini J; Nikolic A; Shalini S; Wilson CH; Norris MD; Haber M; Kumar S, 2026, 'Correction: An unexpected role for caspase-2 in neuroblastoma (Cell Death & Disease, (2014), 5, 8, (e1383), 10.1038/cddis.2014.342)', Cell Death and Disease, 17, http://dx.doi.org/10.1038/s41419-026-09023-2

McKay CJL; Mayoh C; Power P; Jessop S; Sriharan S; Staunton J; Trinder S; Zhukova N; Mignone C; Govender D; Alvaro F; Downie P; Hansford JR; Hassall T; Valvi S; Mateos MK; Barahona P; Gifford AJ; Tax G; Tsoli M; Dolman EM; Wong M; Cowley M; Marshall GM; Trahair TN; Ekert PG; Haber M; Tyrell V; Lau LMS; Manoharan N; Ziegler DS; Khuong-Quang DA, 2026, 'Precision-guided therapy in H3K27-altered diffuse midline glioma', Nature Communications, 17, http://dx.doi.org/10.1038/s41467-026-73304-9

Soria-Bretones I; Casás-Selves M; Samanta M; Groff D; Murray J; Fletcher JI; Farrel A; Pastor S; Patel K; Goodfellow E; Li L; Caron C; Shiwram A; Kim H; Henry D; Laterreur N; Bowlan J; Krytska K; Neuhauser SB; Stearns TM; Schubert JA; Wu J; Surrey LF; Martinez D; Mak C; Brand J; Wesley C; Somers K; Álvarez-Quilón A; Vallée F; Nejad P; Schonhoft JD; Li J; Veloso A; Young JTF; Hyer ML; Morris SJ; Mossé YP; Marshall CG; Haber M; Zimmermann M; Maris JM, 2026, 'The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity', Nature Communications, 17, http://dx.doi.org/10.1038/s41467-026-74061-5

Hetherington K; Hunter JD; Donoghoe MW; McGillycuddy M; McGill BC; Robertson EG; Tyrrell V; Lau LMS; Marron JM; Tucker KM; Marshall GM; Vetsch J; Haber M; Malkin D; Mateos MK; O’Brien TA; Ziegler DS; Wakefield CE, 2026, 'Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer', npj Genomic Medicine, http://dx.doi.org/10.1038/s41525-026-00591-y

Fordham AM; Brown LM; Mayoh C; Salib A; Barger ZA; Wong M; Lim Kam Sian TCC; Hu C; Xie J; Gunther K; Trebilcock P; Terry RL; Barahona P; Ajuyah P; Sherstyuk A; Avila A; Cadiz R; Perkins CM; Gifford AJ; Mao J; Dolman MEM; Zhao A; O’Regan LP; Gorgels D; Lau LMS; Ziegler DS; Haber M; Tyrrell V; Lock RB; Cowley MJ; Nicholls W; Daly RJ; Ekert PG; Fleuren EDG, 2026, 'Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young', Molecular Cancer Therapeutics, 25, pp. 1077 - 1094, http://dx.doi.org/10.1158/1535-7163.mct-25-0736

Hetherington K; Hunter J; Donoghoe M; McGillycuddy M; McGill B; Robertson E; Tyrrell V; Lau L; Marron J; Tucker K; Marshall G; Vetsch J; Haber M; Malkin D; Mateos M; Brien TO; Ziegler D; Wakefield C, 2026, 'ID #107 Family experiences of precision-guided treatment recommendations for poor prognosis paediatric Central Nervous System (CNS) cancer', Neuro-Oncology Pediatrics, 2, pp. wuag026.020, http://dx.doi.org/10.1093/neuped/wuag026.020

Mateos M; Manoharan N; Anh D; Quang K; Chen W; Salomon R; Shale C; Ong F; Sriharan S; Valvi S; Nicholas S; Mayoh C; Toumari M; Li W; El-Kamand S; Wong M; Hansford J; Alvaro F; Bazaz SR; Cui L; Tyrrell V; Cuppen E; Haber M; Ekert P; Priestley P; Ziegler D; Lau L; Cowley M, 2026, 'ID #736 Ultra-sensitive plasma ctDNA assay enables detection of brain tumour DNA in peripheral blood and is prognostic in childhood brain cancer', Neuro-Oncology Pediatrics, 2, pp. wuag026.309, http://dx.doi.org/10.1093/neuped/wuag026.309

Karsa M; Karsa A; Spurling D; Xiao L; Ronca E; Bongers A; Gao W; Gifford AJ; El-Ayoubi A; Cheung LC; Kotecha RS; Lock RB; Teh CE; Lessene G; Norris MD; Wei A; Haber M; Henderson MJ; Moujalled DM; Somers K, 2026, 'BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia', British Journal of Haematology, http://dx.doi.org/10.1111/bjh.70598

Fuentes-Bolanos NA; Courtney EK; Mayoh C; Warby M; Lau LMS; Wong-Erasmus M; Khuong-Quang DA; Barahona P; Padhye B; Warren N; El-Kamand S; Nunag S; Ajuyah P; Sherstyuk A; Altekoester AK; Sullivan A; Poplawski N; Kiraly-Borri C; O’sullivan S; Fan HM; Alli R; Curnow L; Bhatia K; Anazodo A; Trahair TN; Mateos MK; Hansford JR; Dholaria H; Josephi-Taylor S; Moore AS; Nicholls W; Gottardo NG; Downie P; Khaw SL; Tapp H; McCowage G; Dalla-Pozza L; Alvaro F; Wood PJ; Tyrrell V; Haber M; Cowley MJ; Ekert PG; Marshall GM; Kirk J; Tucker K; Pinese M; Ziegler DS, 2026, 'Integrated Germline and Somatic Molecular Profiling to Detect Cancer Predisposition Has a High Clinical Impact in Poor-Prognosis Pediatric Cancer', Clinical Cancer Research, 32, pp. 2047 - 2059, http://dx.doi.org/10.1158/1078-0432.CCR-25-3806

Haber M; Norris MD, 2026, 'Altering the Diet to Rewire Cancer', New England Journal of Medicine, 394, pp. 1447 - 1450, http://dx.doi.org/10.1056/NEJMcibr2516825

Chen J; Nelson C; Wong M; Tee AE; Liu PY; La T; Fletcher JI; Kamili A; Mayoh C; Bartenhagen C; Trahair TN; Xu N; Jayatilleke N; Wong M; Peng H; Atmadibrata B; Cheung BB; Lan Q; Bryan TM; Mestdagh P; Vandesompele J; Combaret V; Boeva V; Wang JY; Janoueix-Lerosey I; Cowley MJ; Mackenzie KL; Dolnikov A; Li J; Polly P; Marshall GM; Reddel RR; Norris MD; Haber M; Fischer M; Zhang XD; Pickett HA; Liu T, 2026, 'Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy (Clin Cancer Res, (2021), 27, (1438–1451), 10.1158/1078-0432.CCR-20-3044)', Clinical Cancer Research, 32, pp. 1182, http://dx.doi.org/10.1158/1078-0432.CCR-26-0621

Hanssen KM; Murray J; Pandher R; Alfred S; Gamble LD; Brand J; Mosmann E; Kusuma FK; Mak C; Kearns A; Kamili A; Atkinson C; Minchaca AZ; Bertoldo J; Ziegler DS; Mussai F; Cheng PNM; Norris MD; Fletcher JI; Haber M, 2025, 'Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma', Journal of Experimental and Clinical Cancer Research, 44, http://dx.doi.org/10.1186/s13046-025-03502-8

Atkinson C; Kamili A; Tactacan CM; Jayatilleke N; Rosser SPA; Saletta F; Gana CC; Graber P; Wanninayaka A; Ignacio RMC; Kavallaris M; Gifford AJ; Lock RB; Norris MD; Haber M; Mayoh C; Nath CE; Trahair TN; Fletcher JI, 2025, 'P-glycoprotein as a chemotherapy resistance mechanism and biomarker of poor response in high-risk neuroblastoma', Ejc Paediatric Oncology, 6, pp. 100478, http://dx.doi.org/10.1016/j.ejcped.2025.100478

Lei Y; Hetherington K; Daly R; Rensen N; McGill BC; Ziegler DS; Lau LMS; Tyrrell V; Karpelowsky J; Cowley MJ; Tucker KM; Haber M; Barahona P; Wakefield CE, 2025, 'Data Sharing, Biopsies and Patient Confidentiality in a Precision Medicine Trial for Childhood Cancer: A Mixed Method Study of Parents, Oncologists, and Scientists’ Perspectives', Journal of Personalized Medicine, 15, http://dx.doi.org/10.3390/jpm15110531

Lau LMS; Salomon R; Chen W; Shale C; Toumari M; Li W; Chan J; Razavi-Bazaz S; Cui L; El-Kamand S; Wong M; Cuppen E; Haber M; Tyrrell V; Ekert PG; Ziegler DS; Priestley P; Cowley MJ, 2025, 'Abstract A001-PR009: Whole-genome-based, tumor-informed circulating tumor DNA detection correlates with treatment response and survival of pediatric solid tumor', Cancer Research, 85, pp. a001-pr009-a001-pr009, http://dx.doi.org/10.1158/1538-7445.pediatric25-a001-pr009

Raiti L; Altekoester A; El-Kamand S; Ryan G; Tucker K; Warby M; Courtney E; Barahona P; Lau L; Trahair T; Marshall G; Ziegler D; Haber M; Tyrrell V; Cowley M; Mayoh C; Pinese M; Khuong-Quang D-A; Fuentes-Bolanos N, 2025, 'Abstract A044: The biology of childhood tumors with germline CHEK2 loss of function variants', Cancer Research, 85, pp. a044 - a044, http://dx.doi.org/10.1158/1538-7445.pediatric25-a044

Fuentes-Bolanos NA; Sylvester D; Courtney E; Mayoh C; Warby M; Khuong Quang DA; Barahona P; Sullivan A; Altekoester A; Rumford M; Dholaria H; Wong M; Tyrrell V; Haber M; Tucker K; Cowley MJ; Ziegler DS; Pinese M; Lau LMS, 2025, 'Abstract A045: Cooperation between germline and somatic drivers in childhood cancer: insights from the ZERO cohort', Cancer Research, 85, pp. a045 - a045, http://dx.doi.org/10.1158/1538-7445.pediatric25-a045

Body A; Lal L; Downie P; Anazodo A; O’Brien T; Padhye B; Fuentes-Bolanos N; Srihari S; Ahern ES; Haber M; Smith C; Lineburg K; Turville S; Naing Z; Rawlinson W; Buttery J; Raina MacIntyre C; Milch V; Segelov E, 2025, 'Immune Response to COVID-19 Vaccination in Children With Cancer', Pediatrics, 156, http://dx.doi.org/10.1542/peds.2024-070209

Azzam N; Fletcher JI; Melong N; Lau LMS; Dolman EM; Mao J; Tax G; Cadiz R; Tuzi L; Kamili A; Dumevska B; Xie J; Chan JA; Senger DL; Grover SA; Malkin D; Haber M; Berman JN, 2025, 'Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy', Cancer Research Communications, 5, pp. 1215 - 1227, http://dx.doi.org/10.1158/2767-9764.CRC-25-0080

Sansom-Daly UM; McLoone JK; Fardell JE; Evans HE; McGill BC; Robertson EG; Signorelli C; Ellis S; Ha L; Hetherington K; Houweling RE; Nevin SM; Schilstra CE; Mitchell R; Haber M; Cohn RJ; Wakefield CE, 2025, 'Bridging the Gap: Embedding Psychosocial Oncology Research into Comprehensive Cancer Care for Children and Young People', Cancers, 17, pp. 2123 - 2123, http://dx.doi.org/10.3390/cancers17132123

Pandher R; Xue C; Gamble LD; Milazzo G; Giacomo SD; Murray J; Cheung L; Ferrucci F; Palombo M; Purgato S; Burkhart CA; Fedtsova N; Gleiberman AS; Purmal AA; Korotchkina L; Nikiforov MA; Makarov SS; Telfer TJ; Codd R; Marshall GM; Scott DA; Osterman AL; Gudkov AV; Perini G; Haber M; Norris MD, 2025, 'The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response', Proceedings of the National Academy of Sciences of the United States of America, 122, http://dx.doi.org/10.1073/pnas.2420011122

Azfar M; Gao W; Van den Haute C; Xiao L; Karsa M; Pandher R; Karsa A; Spurling D; Ronca E; Bongers A; Guo X; Mayoh C; Fayt Y; Schoofs A; Burns MR; Verhelst SHL; Norris MD; Haber M; Vangheluwe P; Somers K, 2025, 'The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma', Molecular Oncology, 19, pp. 913 - 936, http://dx.doi.org/10.1002/1878-0261.13789

Gao W; Karsa M; Xiao L; Spurling D; Karsa A; Ronca E; Bongers A; Guo X; Mayoh C; Azfar M; Verhelst SHL; Tanaka K; Cheung LC; Kotecha RS; Lock RB; Burns MR; Vangheluwe P; Norris MD; Haber M; Somers K, 2025, 'Polyamine depletion limits progression of acute leukaemia', International Journal of Cancer, http://dx.doi.org/10.1002/ijc.35362

Han JZR; Phimmachanh M; Hastings JF; Leong KH; Ng BH; Ni J; Fontaine-Titley A; Cadell AL; O’Donnell YE; Clearwater M; Kamili A; Haber M; Norris M; Timpson P; Trahair TN; Fletcher JI; Fey D; Kolch W; Latham SL; Croucher DR, 2025, 'Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma', Science Advances, 11, http://dx.doi.org/10.1126/sciadv.ady5599

Rouaen JRC; Salerno A; Shai-Hee T; Murray JE; Castrogiovanni G; McHenry C; Jue TR; Pham V; Bell JL; Poursani E; Valli E; Cazzoli R; Damstra N; Nelson DJ; Stevens KLP; Chee J; Slapetova I; Kasherman M; Whan R; Lin F; Cochran BJ; Tedla N; Veli FC; Yuksel A; Mayoh C; Saletta F; Mercatelli D; Chtanova T; Kulasinghe A; Catchpoole D; Cirillo G; Biro M; Lode HN; Luciani F; Haber M; Gray JC; Trahair TN; Vittorio O, 2024, 'Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma', Nature Communications, 15, pp. 10462, http://dx.doi.org/10.1038/s41467-024-54689-x

Cheung BB; Mittra R; Murray J; Wang Q; Seneviratne JA; Raipuria M; Wong IPL; Restuccia D; Gifford A; Salib A; Sutton S; Huang L; Ferdowsi PV; Tsang J; Sekyere E; Mayoh C; Luo L; Brown DL; Stow JL; Zhu S; Young RJ; Solomon BJ; Chappaz S; Kile B; Kueh A; Herold MJ; Hilton DJ; Liu T; Norris MD; Haber M; Carter DR; Parker MW; Marshall GM, 2024, 'Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis', Communications Biology, 7, pp. 1322, http://dx.doi.org/10.1038/s42003-024-06899-8

Nelson CB; Rogers S; Roychoudhury K; Tan YS; Atkinson CJ; Sobinoff AP; Tomlinson CG; Hsu A; Lu R; Dray E; Haber M; Fletcher JI; Cesare AJ; Hegde RS; Pickett HA, 2024, 'The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-45683-4

Murray JE; Valli E; Milazzo G; Mayoh C; Gifford AJ; Fletcher JI; Xue C; Jayatilleke N; Salehzadeh F; Gamble LD; Rouaen JRC; Carter DR; Forgham H; Sekyere EO; Keating J; Eden G; Allan S; Alfred S; Kusuma FK; Clark A; Webber H; Russell AJ; de Weck A; Kile BT; Santulli M; De Rosa P; Fleuren EDG; Gao W; Wilkinson-White L; Low JKK; Mackay JP; Marshall GM; Hilton DJ; Giorgi FM; Koster J; Perini G; Haber M; Norris MD, 2024, 'The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-49871-0

Seneviratne JA; Ravindrarajah D; Carter DR; Zhai V; Lalwani A; Krishan S; Balachandran A; Ng E; Pandher R; Wong M; Nero TL; Wang S; Norris MD; Haber M; Liu T; Parker MW; Cheung BB; Marshall GM, 2024, 'Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma', Cancer Medicine, 13, pp. e70082, http://dx.doi.org/10.1002/cam4.70082

Hu W; Kumar A; Ahmed SF; Qi S; Ma DKG; Chen H; Singh GJ; Casan JML; Haber M; Voskoboinik I; McKay MR; Trapani JA; Ekert PG; Fareh M, 2024, 'Single-base tiled screen unveils design principles of PspCas13b for potent and off-target-free RNA silencing', Nature Structural and Molecular Biology, 31, pp. 1702 - 1716, http://dx.doi.org/10.1038/s41594-024-01336-0

Hassan N; Yi H; Malik B; Gaspard-Boulinc L; Samaraweera SE; Casolari DA; Seneviratne J; Balachandran A; Chew T; Duly A; Carter DR; Cheung BB; Norris M; Haber M; Kavallaris M; Marshall GM; Zhang XD; Liu T; Wang J; Liebermann DA; D'Andrea RJ; Wang JY, 2024, 'Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML', Blood, 144, pp. 84 - 98, http://dx.doi.org/10.1182/blood.2024024072

Lau LMS; Khuong-Quang DA; Mayoh C; Wong M; Barahona P; Ajuyah P; Senapati A; Nagabushan S; Sherstyuk A; Altekoester AK; Fuentes-Bolanos NA; Yeung V; Sullivan A; Omer N; Diamond Y; Jessop S; Battaglia L; Zhukova N; Cui L; Lin A; Gifford AJ; Fleuren EDG; Dalla-Pozza L; Moore AS; Khaw SL; Eisenstat DD; Gottardo NG; Wood PJ; Tapp H; Alvaro F; McCowage G; Nicholls W; Hansford JR; Manoharan N; Kotecha RS; Mateos MK; Lock RB; Tyrrell V; Haber M; Trahair TN; Cowley MJ; Ekert PG; Marshall GM; Ziegler DS; Wong-Erasmus M, 2024, 'Precision-guided treatment in high-risk pediatric cancers', Nature Medicine, 30, pp. 1913 - 1922, http://dx.doi.org/10.1038/s41591-024-03044-0

Karsa M; Xiao L; Ronca E; Bongers A; Spurling D; Karsa A; Cantilena S; Mariana A; Failes TW; Arndt GM; Cheung LC; Kotecha RS; Sutton R; Lock RB; Williams O; de Boer J; Haber M; Norris MD; Henderson MJ; Somers K, 2024, 'FDA-approved disulfiram as a novel treatment for aggressive leukemia', Journal of Molecular Medicine, 102, pp. 507 - 519, http://dx.doi.org/10.1007/s00109-023-02414-4

Hogarty MD; Ziegler DS; Franson A; Chi YY; Tsao-Wei D; Liu K; Vemu R; Gerner EW; Bruckheimer E; Shamirian A; Hasenauer B; Balis FM; Groshen S; Norris MD; Haber M; Park JR; Matthay KK; Marachelian A, 2024, 'Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial', British Journal of Cancer, 130, pp. 788 - 797, http://dx.doi.org/10.1038/s41416-023-02525-2

Mayoh C; Gifford AJ; Terry R; Lau LMS; Wong M; Rao P; Shai-Hee T; Saletta F; Khuong-Quang DA; Qin V; Mateos MK; Meyran D; Miller KE; Yuksel A; Mould EVA; Bowen-James R; Govender D; Senapati A; Zhukova N; Omer N; Dholaria H; Alvaro F; Tapp H; Diamond Y; Pozza LD; Moore AS; Nicholls W; Gottardo NG; McCowage G; Hansford JR; Khaw SL; Wood PJ; Catchpoole D; Cottrell CE; Mardis ER; Marshall GM; Tyrrell V; Haber M; Ziegler DS; Vittorio O; Trapani JA; Cowley MJ; Neeson PJ; Ekert PG, 2023, 'A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer', Genome Medicine, 15, http://dx.doi.org/10.1186/s13073-023-01170-x

Murray J; Pandher R; Xiao L; Somers K; Brand J; Mosmann E; Alfred S; Kusuma F; Kearns A; Park JR; Marshall LV; Gorrini C; Chesler L; Hogarty MD; Pearson ADJ; Burns M; Fletcher JI; Ziegler D; Norris MD; Haber M, 2023, 'Abstract B132: Addition of AMXT1501 (polyamine uptake inhibitor) plus DFMO (polyamine synthesis inhibitor) to standard-of-care chemotherapy/anti-GD2 antibody in the TH-MYCN mouse neuroblastoma model, enhances efficacy compared to addition of DFMO alone', Molecular Cancer Therapeutics, 22, pp. b132 - b132, http://dx.doi.org/10.1158/1535-7163.targ-23-b132

Ajuyah P; Mayoh C; Lau LMS; Barahona P; Wong M; Chambers H; Valdes-Mora F; Senapati A; Gifford AJ; D’Arcy C; Hansford JR; Manoharan N; Nicholls W; Williams MM; Wood PJ; Cowley MJ; Tyrrell V; Haber M; Ekert PG; Ziegler DS; Khuong-Quang DA, 2023, 'Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes', Scientific Reports, 13, pp. 3775, http://dx.doi.org/10.1038/s41598-023-30395-4

Wakefield CE; Hetherington K; Robertson EG; Donoghoe MW; Hunter JD; Vetsch J; Marron JM; Tucker KM; Marshall GM; Broom A; Haber M; Tyrrell V; Malkin D; Lau L; Mateos MK; O’Brien TA; Ziegler DS, 2023, 'Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives', British Journal of Cancer, 129, pp. 1634 - 1644, http://dx.doi.org/10.1038/s41416-023-02429-1

Zhai L; Balachandran A; Larkin R; Seneviratne JA; Chung SA; Lalwani A; Tsubota S; Beck D; Kadomatsu K; Beckers A; Durink K; De Preter K; Speleman F; Haber M; Norris MD; Swarbrick A; Cheung BB; Marshall GM; Carter DR, 2023, 'Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms242115571

Mayoh C; Mao J; Xie J; Tax G; Chow SO; Cadiz R; Pazaky K; Barahona P; Ajuyah P; Trebilcock P; Malquori A; Gunther K; Avila A; Yun DY; Alfred S; Gopalakrishnan A; Kamili A; Wong M; Cowley MJ; Jessop S; Lau LMS; Trahair TN; Ziegler DS; Fletcher JI; Gifford AJ; Tsoli M; Marshall GM; Haber M; Tyrrell V; Failes TW; Arndt GM; Lock RB; Ekert PG; M Dolman ME; Wong-Erasmus M; Ajuyah P, 2023, 'High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer', Cancer Research, 83, pp. 2716 - 2732, http://dx.doi.org/10.1158/0008-5472.CAN-22-3702

Daly R; Hetherington K; Hazell E; Wadling BR; Tyrrell V; Tucker KM; Marshall GM; Ziegler DS; Lau LMS; Trahair TN; O’Brien TA; Collins K; Gifford AJ; Haber M; Pinese M; Malkin D; Cowley MJ; Karpelowsky J; Drew D; Jacobs C; Wakefield CE, 2023, 'Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial', Journal of Personalized Medicine, 13, http://dx.doi.org/10.3390/jpm13071033

Moles E; Howard CB; Huda P; Karsa M; McCalmont H; Kimpton K; Duly A; Chen Y; Huang Y; Tursky ML; Ma D; Bustamante S; Pickford R; Connerty P; Omari S; Jolly CJ; Joshi S; Shen S; Pimanda JE; Dolnikov A; Cheung LC; Kotecha RS; Norris MD; Haber M; de Bock CE; Somers K; Lock RB; Thurecht KJ; Kavallaris M, 2023, 'Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia', Science translational medicine, 15, pp. eabm1262 - eabm1262, http://dx.doi.org/10.1126/scitranslmed.abm1262

Hastings JF; Latham SL; Kamili A; Wheatley MS; Han JZR; Wong-Erasmus M; Phimmachanh M; Nobis M; Pantarelli C; Cadell AL; O’Donnell YEI; Leong KH; Lynn S; Geng FS; Cui L; Yan S; Achinger-Kawecka J; Stirzaker C; Norris MD; Haber M; Trahair TN; Speleman F; De Preter K; Cowley MJ; Bogdanovic O; Timpson P; Cox TR; Kolch W; Fletcher JI; Fey D; Croucher DR, 2023, 'Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.abp8314

Ballinger ML; Pattnaik S; Mundra PA; Zaheed M; Rath E; Priestley P; Baber J; Ray-Coquard I; Isambert N; Causeret S; van der Graaf WTA; Puri A; Duffaud F; Le Cesne A; Seddon B; Chandrasekar C; Schiffman JD; Brohl AS; James PA; Kurtz JE; Penel N; Myklebost O; Meza-Zepeda LA; Pickett H; Kansara M; Waddell N; Kondrashova O; Pearson JV; Barbour AP; Li S; Nguyen TL; Fatkin D; Graham RM; Giannoulatou E; Green MJ; Kaplan W; Ravishankar S; Copty J; Powell JE; Cuppen E; van Eijk K; Veldink J; Ahn JH; Kim JE; Lor Randall R; Tucker K; Judson I; Sarin R; Ludwig T; Genin E; Deleuze JF; Haber M; Marshall G; Cairns MJ; Blay JY; Thomas DM, 2023, 'Heritable defects in telomere and mitotic function selectively predispose to sarcomas', Science, 379, pp. 253 - 260, http://dx.doi.org/10.1126/science.abj4784

Novototskaya-Vlasova KA; Neznanov NS; Molodtsov I; Hall BM; Commane M; Gleiberman AS; Murray J; Haber M; Norris MD; Leonova KI; Gudkov AV, 2022, 'Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors', Proceedings of the National Academy of Sciences of the United States of America, 119, http://dx.doi.org/10.1073/pnas.2213146119

Tang TCY; Xu N; Nordon R; Haber M; Micklethwaite K; Dolnikov A, 2022, 'Donor T cells for CAR T cell therapy', Biomarker Research, 10, http://dx.doi.org/10.1186/s40364-022-00359-3

Hanssen KM; Wheatley MS; Yu DMT; Conseil G; Norris MD; Haber M; Cole SPC; Fletcher JI, 2022, 'GSH facilitates the binding and inhibitory activity of novel multidrug resistance protein 1 (MRP1) modulators', FEBS Journal, 289, pp. 3854 - 3875, http://dx.doi.org/10.1111/febs.16374

Xiao L; Karsa M; Ronca E; Bongers A; Kosciolek A; El-Ayoubi A; Revalde JL; Seneviratne JA; Cheung BB; Cheung LC; Kotecha RS; Newbold A; Bjelosevic S; Arndt GM; Lock RB; Johnstone RW; Gudkov AV; Gurova KV; Haber M; Norris MD; Henderson MJ; Somers K, 2022, 'The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.863329

Lau LMS; Mayoh C; Xie J; Barahona P; MacKenzie KL; Wong M; Kamili A; Tsoli M; Failes TW; Kumar A; Mould EVA; Gifford A; Chow SO; Pinese M; Fletcher JI; Arndt GM; Khuong-Quang DA; Wadham C; Batey D; Eden G; Trebilcock P; Joshi S; Alfred S; Gopalakrishnan A; Khan A; Grebert Wade D; Strong PA; Manouvrier E; Morgan LT; Span M; Lim JY; Cadiz R; Ung C; Thomas DM; Tucker KM; Warby M; McCowage GB; Dalla-Pozza L; Byrne JA; Saletta F; Fellowes A; Fox SB; Norris MD; Tyrrell V; Trahair TN; Lock RB; Cowley MJ; Ekert PG; Haber M; Ziegler DS; Marshall GM, 2022, 'In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer', EMBO Molecular Medicine, 14, pp. emmm202114608, http://dx.doi.org/10.15252/emmm.202114608

Gao J; Jung M; Williams RT; Hui D; Russell AJ; Naim AJ; Kamili A; Clifton M; Bongers A; Mayoh C; Ho G; Scott CL; Jessup W; Haber M; Norris MD; Henderson MJ, 2022, 'Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian Cancer', Cancers, 14, http://dx.doi.org/10.3390/cancers14081878

Back to profile page